Short Interest in ENDRA Life Sciences Inc. (NASDAQ:NDRA) Rises By 167.7%

by · The Cerbat Gem

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) was the recipient of a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 717,700 shares, an increase of 167.7% from the September 30th total of 268,100 shares. Approximately 4.0% of the company’s shares are sold short. Based on an average daily trading volume, of 9,790,000 shares, the days-to-cover ratio is presently 0.1 days.

ENDRA Life Sciences Stock Performance

Shares of ENDRA Life Sciences stock opened at $0.28 on Friday. The stock has a 50 day moving average of $0.28 and a 200 day moving average of $284.82. The firm has a market capitalization of $4.84 million, a price-to-earnings ratio of -0.01 and a beta of 0.79. ENDRA Life Sciences has a fifty-two week low of $0.18 and a fifty-two week high of $139.50.

ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($4.00) EPS for the quarter, missing the consensus estimate of ($3.50) by ($0.50). Analysts forecast that ENDRA Life Sciences will post -11.08 EPS for the current year.

ENDRA Life Sciences Company Profile

(Get Free Report)

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.

Featured Articles